Form D · Biotechnology
Circula-AI Inc
Boca Raton, FL · CIK 0002055042
Offering snapshot reported Mar 26, 2026 · SEC filing
- Reported sold
- $1.15M Offering amount: $2.1M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 18, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 26, 2026 | Initial | $1,150,932 | No comparison | 7 | SEC filing |
| Nov 6, 2025 | Initial | $2,238,373 | No comparison | 9 | SEC filing |
| Sep 3, 2025 | Initial | $1,670,428 | No comparison | 7 | SEC filing |
| May 23, 2025 | Initial | $350,780 | No comparison | 10 | SEC filing |
| Mar 13, 2025 | Initial | $2,204,428 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-577726
Source: Form D, filed Mar 26, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Cassandra Davies | Executive |
| Prue Freestone | Director |
| Albert F Hummel | Director, Executive |
| Brock Smith | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1199 South Federal Hwy Ste 291
Boca Raton, FL, 33432
Boca Raton, FL, 33432